Abzena Welcomes Taylor Boyd as New CBO
Boyd has a strong track record of success within the life sciences and CDMO industry, primarily in strategic transactions and capital-raising activities.
Antibodies | 27/02/2025 | By Aishwarya
AstraZeneca Acquires Fusion Pharmaceuticals to Transform Cancer Treatment
Fusion Pharmaceuticals Inc. has signed a definitive agreement to be acquired by AstraZeneca.
Antibodies | 20/03/2024 | By Manvi | 288
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy